Suggestions
John Doyle
Global Chief Technology Officer, Healthcare & Life Sciences at Microsoft
John Doyle is the Global Chief Technology Officer for Healthcare & Life Sciences at Microsoft.4 In this role, he is responsible for developing technology strategy and partnerships across the Healthcare and Life Sciences industry.12 Doyle engages deeply with industry customers, partners, analysts, and product engineering teams to create strategies and integrated technology capabilities that harness the power of cloud and AI to drive innovation and accelerate industry transformation.12
Doyle has been with Microsoft since 2013, initially starting as Lead Technology Strategist for Healthcare & Life Sciences in the UK.4 He then progressed to Senior Director of Global Business Strategy for Healthcare & Life Sciences before assuming his current role as Global CTO in January 2020.4
Prior to joining Microsoft, Doyle held various leadership positions in technology and consulting firms, including roles at Trustmarque and Bull.4 He has a strong background in technology strategy and transformation, particularly in the healthcare and life sciences sectors.
Doyle is also a member of the Forbes Technology Council4, indicating his recognition as a thought leader in the technology industry. He is known for his expertise in areas such as cloud computing, AI, and digital transformation in healthcare.3
Highlights
From accelerating rare disease research at Amgen to powering better patient care at Teladoc Health, more and more healthcare and life sciences companies are realizing the potential for AI to transform their businesses.
“We now use Copilot on a daily basis. There’s no corner of the business that’s going to be untouched by AI tools paired with human expertise.” —Dr. David Reese, EVP & CTO, Amgen
“Copilot saves us thousands of hours as an enterprise just through eliminating daily processes—it’s driving operational efficiency across Teladoc, like a personal assistant that never sleeps.” —Eddie Swafford, Vice President of Operations, Teladoc Health.
To learn more read our blog: https://lnkd.in/gHBeK3Wx
#Microsoft #Healthcare #AI #Copilot
Healthcare and Life Sciences ahead of other industries in AI adoption, in terms of the number of AI models in production. On average, H&LS organizations have deployed over 170 models in production, compared to 159 for all other sectors.
Around half (48%) of H&LS respondents to a study conducted by 451 Research and commissioned by Vultr said they view AI as the most significant technological advancement poised to impact industrial networking over the next five years, with 49% expecting AI to improve network management across both IT and OT systems, with 93% of H&LS organizations planning to increase their AI spend in 2025.
H&LS organizations performed more strongly across core business indicators:
- 82% reported doing moderately or significant better in terms of revenue.
- 81% shared that their organization did moderately of significantly better in regard to customer satisfactions.
- 80% saw improvements across marketing (conversion rates, ROAS cost per customer acquisition).
To learn more: https://lnkd.in/gSMMRXM9
#Healthcare #AI #Adoption
